{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T10:14:14Z","timestamp":1725531254392},"publisher-location":"Totowa, NJ","reference-count":40,"publisher":"Humana Press","isbn-type":[{"type":"print","value":"9781603270021"},{"type":"electronic","value":"9781603270038"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009]]},"DOI":"10.1007\/978-1-60327-003-8_10","type":"book-chapter","created":{"date-parts":[[2009,4,18]],"date-time":"2009-04-18T23:21:45Z","timestamp":1240096905000},"page":"175-190","source":"Crossref","is-referenced-by-count":5,"title":["Dissecting the Urokinase Activation Pathway Using Urokinase-Activated Anthrax Toxin"],"prefix":"10.1007","author":[{"given":"Shihui","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas H.","family":"Bugge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arthur E.","family":"Frankel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen H.","family":"Leppla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,1,22]]},"reference":[{"key":"10_CR1_10","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/B978-012088445-2\/50023-8","volume-title":"The Comprehensive Sourcebook of Bacterial Protein Toxins","author":"S.H. Leppla","year":"2006","unstructured":"1. Leppla, S.H. (2006) Bacillus anthracis toxins. In: J. E. Alouf and M. R. Popoff (eds.), The Comprehensive Sourcebook of Bacterial Protein Toxins. Academic: Burlington, MA, pp. 323\u2013347."},{"key":"10_CR2_10","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/n35101999","volume":"414","author":"K.A. Bradley","year":"2001","unstructured":"2. Bradley, K.A., Mogridge, J., Mourez, M., Collier, R.J. and Young, J.A. (2001) Identification of the cellular receptor for anthrax toxin. Nature 414, 225\u2013229.","journal-title":"Nature"},{"key":"10_CR3_10","doi-asserted-by":"publisher","first-page":"5170","DOI":"10.1073\/pnas.0431098100","volume":"100","author":"H.M. Scobie","year":"2003","unstructured":"3. Scobie, H.M., Rainey, G.J., Bradley, K.A. and Young, J.A. (2003) Human capillary morphogenesis protein 2 functions as an anthrax toxin receptor. Proc. Natl. Acad. Sci. USA 100, 5170\u20135174.","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10_CR4_10","doi-asserted-by":"publisher","first-page":"7049","DOI":"10.1073\/pnas.062160399","volume":"99","author":"K. Cunningham","year":"2002","unstructured":"4. Cunningham, K., Lacy, D.B., Mogridge, J. and Collier, R.J. (2002) Mapping the lethal factor and edema factor binding sites on oligomeric anthrax protective antigen. Proc. Natl. Acad. Sci. USA 99, 7049\u20137053.","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10_CR5_10","doi-asserted-by":"publisher","first-page":"7045","DOI":"10.1073\/pnas.052160199","volume":"99","author":"J. Mogridge","year":"2002","unstructured":"5. Mogridge, J., Cunningham, K., Lacy, D.B., Mourez, M. and Collier, R.J. (2002) The lethal and edema factors of anthrax toxin bind only to oligomeric forms of the protective antigen. Proc. Natl. Acad. Sci. USA 99, 7045\u20137048.","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10_CR6_10","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1083\/jcb.200211018","volume":"160","author":"L. Abrami","year":"2003","unstructured":"6. Abrami, L., Liu, S., Cosson, P., Leppla, S.H. and van der Goot, F.G. (2003) Anthrax toxin triggers endocytosis of its receptor via a lipid raft-mediated clathrin-dependent process. J. Cell Biol. 160, 321\u2013328.","journal-title":"J. Cell Biol."},{"key":"10_CR7_10","doi-asserted-by":"publisher","first-page":"5227","DOI":"10.1074\/jbc.M210321200","volume":"278","author":"S. Liu","year":"2003","unstructured":"7. Liu, S. and Leppla, S.H. (2003) Cell surface tumor endothelium marker 8 cytoplasmic tail-independent anthrax toxin binding, proteolytic processing, oligomer formation, and internalization. J. Biol. Chem. 278, 5227\u20135234.","journal-title":"J. Biol. Chem."},{"key":"10_CR8_10","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1128\/IAI.45.3.761-767.1984","volume":"45","author":"J.W. Ezzell","year":"1984","unstructured":"8. Ezzell, J.W., Ivins, B.E. and Leppla, S.H. (1984) Immunoelectrophoretic analysis, toxicity, and kinetics of in vitro production of the protective antigen and lethal factor components of Bacillus anthracis toxin. Infect. Immun. 45, 761\u2013767.","journal-title":"Infect. Immun."},{"key":"10_CR9_10","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1128\/JB.83.6.1274-1280.1962","volume":"83","author":"F.A. Beall","year":"1962","unstructured":"9. Beall, F.A., Taylor, M.J. and Thorne, C.B. (1962) Rapid lethal effect in rats of a third component found upon fractionating the toxin of Bacillus anthracis. J. Bacteriol. 83, 1274\u20131280.","journal-title":"J. Bacteriol."},{"key":"10_CR10_10","doi-asserted-by":"crossref","first-page":"7123","DOI":"10.1016\/S0021-9258(17)38364-3","volume":"261","author":"A.M. Friedlander","year":"1986","unstructured":"10. Friedlander, A.M. (1986) Macrophages are sensitive to anthrax lethal toxin through an acid-dependent process. J. Biol. Chem. 261, 7123\u20137126.","journal-title":"J. Biol. Chem."},{"key":"10_CR11_10","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1126\/science.280.5364.734","volume":"280","author":"N.S. Duesbery","year":"1998","unstructured":"11. Duesbery, N.S., Webb, C.P., Leppla, S.H., Gordon, V.M., Klimpel, K.R., Copeland, T.D., Ahn, N.G., Oskarsson, M.K., Fukasawa, K., Paull, K.D. and Vande Woude, G.F. (1998) Proteolytic inactivation of MAP-kinase-kinase by anthrax lethal factor. Science 280, 734\u2013737.","journal-title":"Science"},{"key":"10_CR12_10","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1006\/bbrc.1998.9040","volume":"248","author":"G. Vitale","year":"1998","unstructured":"12. Vitale, G., Pellizzari, R., Recchi, C., Napolitani, G., Mock, M. and Montecucco, C. (1998) Anthrax lethal factor cleaves the N-terminus of MAPKKs and induces tyrosine\/threonine phosphorylation of MAPKs in cultured macrophages. Biochem. Biophys. Res. Commun. 248, 706\u2013711.","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10_CR13_10","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1016\/S0002-9440(10)61218-7","volume":"167","author":"A.M. Firoved","year":"2005","unstructured":"13. Firoved, A.M., Miller, G.F., Moayeri, M., Kakkar, R., Shen, Y., Wiggins, J.F., McNally, E.M., Tang, W.J. and Leppla, S.H. (2005) Bacillus anthracis edema toxin causes extensive tissue lesions and rapid lethality in mice. Am. J. Pathol. 167, 1309\u20131320.","journal-title":"Am. J. Pathol."},{"key":"10_CR14_10","doi-asserted-by":"publisher","first-page":"3162","DOI":"10.1073\/pnas.79.10.3162","volume":"79","author":"S.H. Leppla","year":"1982","unstructured":"14. Leppla, S.H. (1982) Anthrax toxin edema factor: a bacterial adenylate cyclase that incr\u00adeases cyclic AMP concentrations of eukaryotic cells. Proc. Natl. Acad. Sci. USA 79, 3162\u20133166.","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10_CR15_10","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1128\/IAI.47.1.306-310.1985","volume":"47","author":"J. O\u2019Brien","year":"1985","unstructured":"15. O\u2019Brien, J., Friedlander, A., Dreier, T., Ezzell, J. and Leppla, S. (1985) Effects of anthrax toxin components on human neutrophils. Infect. Immun. 47, 306\u2013310.","journal-title":"Infect. Immun."},{"key":"10_CR16_10","doi-asserted-by":"crossref","first-page":"15542","DOI":"10.1016\/S0021-9258(19)49569-0","volume":"267","author":"N. Arora","year":"1992","unstructured":"16. Arora, N., Klimpel, K.R., Singh, Y. and Leppla, S.H. (1992) Fusions of anthrax toxin lethal factor to the ADP-ribosylation domain of Pseudomonas exotoxin A are potent cytotoxins which are translocated to the cytosol of mammalian cells. J. Biol. Chem. 267, 15542\u201315548.","journal-title":"J. Biol. Chem."},{"key":"10_CR17_10","doi-asserted-by":"crossref","first-page":"3334","DOI":"10.1016\/S0021-9258(18)53698-X","volume":"268","author":"N. Arora","year":"1993","unstructured":"17. Arora, N. and Leppla, S.H. (1993) Residues 1\u2013254 of anthrax toxin lethal factor are sufficient to cause cellular uptake of fused polypeptides. J. Biol. Chem. 268, 3334\u20133341.","journal-title":"J. Biol. Chem."},{"key":"10_CR18_10","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1111\/j.1365-2958.1995.tb02375.x","volume":"15","author":"J.C. Milne","year":"1995","unstructured":"18. Milne, J.C., Blanke, S.R., Hanna, P.C. and Collier, R.J. (1995) Protective antigen-binding domain of anthrax lethal factor mediates translocation of a heterologous protein fused to its amino- or carboxy- terminus. Mol. Microbiol. 15, 661\u2013666.","journal-title":"Mol. Microbiol."},{"key":"10_CR19_10","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/nmeth862","volume":"3","author":"J.P. Hobson","year":"2006","unstructured":"19. Hobson, J.P., Liu, S., Rono, B., Leppla, S.H. and Bugge, T.H. (2006) Imaging specific cell-surface proteolytic activity in single living cells. Nat. Methods 3, 259\u2013261.","journal-title":"Nat. Methods"},{"key":"10_CR20_10","first-page":"6061","volume":"60","author":"S. Liu","year":"2000","unstructured":"20. Liu, S., Netzel-Arnett, S., Birkedal-Hansen, H.and Leppla, S.H. (2000) Tumor cell-selective cytotoxicity of matrix metalloproteinase-activated anthrax toxin. Cancer Res. 60, 6061\u20136067.","journal-title":"Cancer Res."},{"key":"10_CR21_10","doi-asserted-by":"publisher","first-page":"17976","DOI":"10.1074\/jbc.M011085200","volume":"276","author":"S. Liu","year":"2001","unstructured":"21. Liu, S., Bugge, T.H. and Leppla, S.H. (2001) Targeting of tumor cells by cell surface urokinase plasminogen activator-dependent anthrax toxin, J. Biol. Chem. 276, 17976\u201317984.","journal-title":"J. Biol. Chem."},{"key":"10_CR22_10","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1073\/pnas.0236849100","volume":"100","author":"S. Liu","year":"2003","unstructured":"22. Liu, S., Aaronson, H., Mitola, D.J., Leppla, S.H. and Bugge, T.H. (2003) Potent antitumor activity of a urokinase-activated engineered anthrax toxin. Proc. Natl. Acad. Sci. USA 100, 657\u2013662.","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10_CR23_10","doi-asserted-by":"publisher","first-page":"16603","DOI":"10.1074\/jbc.272.26.16603","volume":"272","author":"S.H. Ke","year":"1997","unstructured":"23. Ke, S.H., Coombs, G.S., Tachias, K., Navre, M., Corey, D.R. and Madison, E.L. (1997) Distinguishing the specificities of closely related proteases. Role of P3 in substrate and inhibitor discrimination between tissue-type plasminogen activator and urokinase. J. Biol. Chem. 272, 16603\u201316609.","journal-title":"J. Biol. Chem."},{"key":"10_CR24_10","doi-asserted-by":"publisher","first-page":"20456","DOI":"10.1074\/jbc.272.33.20456","volume":"272","author":"S.H. Ke","year":"1997","unstructured":"24. Ke, S.H., Coombs, G.S., Tachias, K., Corey, D.R. and Madison, E.L. (1997) Optimal subsite occupancy and design of a selective inhibitor of urokinase. J. Biol. Chem. 272, 20456\u201320462.","journal-title":"J. Biol. Chem."},{"key":"10_CR25_10","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1517\/14712598.3.5.843","volume":"3","author":"S. Liu","year":"2003","unstructured":"25. Liu, S., Schubert, R.L., Bugge, T.H. and Leppla, S.H. (2003) Anthrax toxin: structures, functions and tumour targeting. Expert Opin. Biol. Ther. 3, 843\u2013853.","journal-title":"Expert Opin. Biol. Ther."},{"key":"10_CR26_10","doi-asserted-by":"crossref","first-page":"19103","DOI":"10.1016\/S0021-9258(19)47273-6","volume":"264","author":"Y. Singh","year":"1989","unstructured":"26. Singh, Y., Chaudhary, V.K. and Leppla, S.H. (1989) A deleted variant of Bacillus anthracis protective antigen is non-toxic and blocks anthrax toxin action in vivo. J. Biol. Chem. 264, 19103\u201319107.","journal-title":"J. Biol. Chem."},{"key":"10_CR27_10","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1111\/j.1462-5822.2006.00845.x","volume":"9","author":"S. Liu","year":"2007","unstructured":"27. Liu, S., Leung, H.J. and Leppla, S.H. (2007) Characterization of the interaction between anthrax toxin and its cellular receptors. Cell. Microbiol. 9, 977\u2013987.","journal-title":"Cell. Microbiol."},{"key":"10_CR28_10","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1128\/IAI.74.1.682-693.2006","volume":"74","author":"A.P. Pomerantsev","year":"2006","unstructured":"28. Pomerantsev, A.P., Sitaraman, R., Galloway, C.R., Kivovich, V. and Leppla, S.H. (2006) Genome engineering in Bacillus anthracis using Cre recombinase. Infect. Immun. 74, 682\u2013693.","journal-title":"Infect. Immun."},{"key":"10_CR29_10","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1038\/368419a0","volume":"368","author":"P. Carmeliet","year":"1994","unstructured":"29. Carmeliet, P., Schoonjans, L., Kieckens, L., Ream, B., Degen, J., Bronson, R., De, V.R., van den Oord, J.J., Collen, D. and Mulligan, R.C. (1994) Physiological consequences of loss of plasminogen activator gene function in mice. Nature 368, 419\u2013424.","journal-title":"Nature"},{"key":"10_CR30_10","doi-asserted-by":"publisher","first-page":"16886","DOI":"10.1074\/jbc.270.28.16886","volume":"270","author":"T.H. Bugge","year":"1995","unstructured":"30. Bugge, T.H., Suh, T.T., Flick, M.J., Daugherty, C.C., Romer, J., Solberg, H., Ellis, V., Dano, K. and Degen, J.L. (1995) The receptor for urokinase-type plasminogen activator is not essential for mouse development or fertility. J. Biol. Chem. 270, 16886\u201316894.","journal-title":"J. Biol. Chem."},{"key":"10_CR31_10","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1101\/gad.9.7.794","volume":"9","author":"T.H. Bugge","year":"1995","unstructured":"31. Bugge, T.H., Flick, M.J., Daugherty, C.C. and Degen, J.L. (1995) Plasminogen deficiency causes severe thrombosis but is compatible with development and reproduction. Genes Dev. 9, 794\u2013807.","journal-title":"Genes Dev."},{"key":"10_CR32_10","doi-asserted-by":"publisher","first-page":"2746","DOI":"10.1172\/JCI116892","volume":"92","author":"P. Carmeliet","year":"1993","unstructured":"32. Carmeliet, P., Kieckens, L., Schoonjans, L., Ream, B., van Nuffelen, A., Prendergast, G., Cole, M., Bronson, R., Collen, D. and Mulligan, R.C. (1993) Plasminogen activator inhibitor-1 gene-deficient mice. I. Generation by homologous recombination and characterization. J. Clin. Invest. 92, 2746\u20132755.","journal-title":"J. Clin. Invest."},{"key":"10_CR33_10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/(SICI)1097-0215(19970703)72:1<1::AID-IJC1>3.0.CO;2-Z","volume":"72","author":"P.A. Andreasen","year":"1997","unstructured":"33. Andreasen, P.A., Kjoller, L., Christensen, L. and Duffy, M.J. (1997) The urokinase-type plasminogen activator system in cancer metastasis: a review. Int. J. Cancer 72, 1\u201322.","journal-title":"Int. J. Cancer"},{"key":"10_CR34_10","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1111\/j.1699-0463.1999.tb01534.x","volume":"107","author":"K. Dano","year":"1999","unstructured":"34. Dano, K., Romer, J., Nielsen, B.S., Bjorn, S., Pyke, C., Rygaard, J. and Lund, L.R. (1999) Cancer invasion and tissue remodeling--cooperation of protease systems and cell types. APMIS 107, 120\u2013127.","journal-title":"APMIS"},{"key":"10_CR35_10","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1038\/nm0396-287","volume":"2","author":"J. Romer","year":"1996","unstructured":"35. Romer, J., Bugge, T.H., Pyke, C., Lund, L.R., Flick, M.J., Degen, J.L. and Dano, K. (1996) Impaired wound healing in mice with a disrupted plasminogen gene. Nat. Med. 2, 287\u2013292.","journal-title":"Nat. Med."},{"key":"10_CR36_10","doi-asserted-by":"crossref","first-page":"4481","DOI":"10.1242\/dev.127.20.4481","volume":"127","author":"L.R. Lund","year":"2000","unstructured":"36. Lund, L.R., Bjorn, S.F., Sternlicht, M.D., Nielsen, B.S., Solberg, H., Usher, P.A., Osterby, R., Christensen, I.J., Stephens, R.W., Bugge, T.H., Dano, K. and Werb, Z. (2000) Lactational competence and involution of the mouse mammary gland require plasminogen. Development 127, 4481\u20134492.","journal-title":"Development"},{"key":"10_CR37_10","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1038\/13459","volume":"5","author":"S. Heymans","year":"1999","unstructured":"37. Heymans, S., Luttun, A., Nuyens, D., Theilmeier, G., Creemers, E., Moons, L., Dyspersin, G.D., Cleutjens, J.P., Shipley, M., Angellilo, A., Levi, M., Nube, O., Baker, A., Keshet, E., Lupu, F., Herbert, J.M., Smits, J.F., Shapiro, S.D., Baes, M., Borgers, M., Collen, D., Daemen, M.J. and Carmeliet, P. (1999) Inhibition of plasminogen activators or matrix metallo\u00adproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure. Nat. Med. 5, 1135\u20131142.","journal-title":"Nat. Med."},{"key":"10_CR38_10","doi-asserted-by":"publisher","first-page":"6410","DOI":"10.1021\/bi00268a014","volume":"21","author":"L.S. Nielsen","year":"1982","unstructured":"38. Nielsen, L.S., Hansen, J.G., Skriver, L., Wilson, E.L., Kaltoft, K., Zeuthen, J. and Dano, K. (1982) Purification of zymogen to plasminogen activator from human glioblastoma cells by affinity chromatography with monoclonal antibody. Biochemistry 21, 6410\u20136415.","journal-title":"Biochemistry"},{"key":"10_CR39_10","doi-asserted-by":"publisher","first-page":"5899","DOI":"10.1073\/pnas.93.12.5899","volume":"93","author":"T.H. Bugge","year":"1996","unstructured":"39. Bugge, T.H., Flick, M.J., Danton, M.J., Daugherty, C.C., Romer, J., Dano, K., Carmeliet, P., Collen, D. and Degen, J.L. (1996) Urokinase-type plasminogen activator is effective in fibrin clearance in the absence of its receptor or tissue-type plasminogen activator. Proc. Natl. Acad. Sci. USA 93, 5899\u20135904.","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10_CR40_10","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1083\/jcb.140.1.233","volume":"140","author":"P. Carmeliet","year":"1998","unstructured":"40. Carmeliet, P., Moons, L., Dewerchin, M., Rosenberg, S., Herbert, J.M., Lupu, F. and Collen, D. (1998) Receptor-independent role of urokinase-type plasminogen activator in pericellular plasmin and matrix metalloproteinase proteolysis during vascular wound healing in mice. J. Cell Biol. 140, 233\u2013245.","journal-title":"J. Cell Biol."}],"container-title":["Methods in Molecular Biology\u2122","Proteases and Cancer"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-60327-003-8_10.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,4]],"date-time":"2021-10-04T08:38:09Z","timestamp":1633336689000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-60327-003-8_10"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009]]},"ISBN":["9781603270021","9781603270038"],"references-count":40,"URL":"https:\/\/doi.org\/10.1007\/978-1-60327-003-8_10","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"type":"print","value":"1064-3745"},{"type":"electronic","value":"1940-6029"}],"subject":[],"published":{"date-parts":[[2009]]}}}